Cardiac MRI—Update 2020; [Kardiale MRT – Update 2020]

被引：0
作者：
Busse A. [1 ]
Rajagopal R. [2 ]
Yücel S. [3 ]
Beller E. [1 ]
Öner A. [3 ]
Streckenbach F. [1 ]
Cantré D. [1 ]
Ince H. [3 ]
Weber M.-A. [1 ]
Meinel F.G. [1 ]
机构：
[1] Department of Diagnostic and Interventional Radiology, Paediatric Radiology and Neuroradiology, University Medical Center Rostock, Ernst-Heydemann-Str. 6, Rostock
[2] Department of Cardiovascular Radiology and Endovascular Interventions, All India Institute of Medical Sciences, New Delhi
[3] Department of Internal Medicine, Division of Cardiology, University Medical Center Rostock, Rostock
来源：
Der Radiologe | 2020年 / 60卷 / Suppl 1期
关键词：
Artificial intelligence; Ischemic heart disease; Magnetic resonance imaging; Mapping; Myocarditis;
D O I：
10.1007/s00117-020-00687-1
中图分类号：
学科分类号：
摘要：
Purpose: To review emerging techniques in cardiac magnetic resonance imaging (CMR) and their clinical applications with a special emphasis on new technologies, recent trials, and updated guidelines. Technological innovations: The utility of CMR has expanded with the development of new MR sequences, postprocessing techniques, and artificial intelligence-based technologies, which have substantially increased the spectrum, quality, and reliability of information that can be obtained by CMR. Established and emerging indications: The CMR modality has become an irreplaceable tool for diagnosis, treatment guidance and follow-up of patients with ischemic heart disease, myocarditis, and cardiomyopathies. Its role has been further strengthened by recent trials and guidelines. Quantitative mapping techniques are increasingly used for tissue characterization and detection of diffuse myocardial changes including myocardial storage diseases. Practical recommendations: With state-of-the-art CMR sequences, postprocessing techniques and understanding of their interpretation, CMR makes invaluable contributions to provide state-of-the-art diagnostics and care for cardiac patients in a multidisciplinary team. © 2020, Springer Medizin Verlag GmbH, ein Teil von Springer Nature.
引用
收藏
页码：33 / 40
页数：7
相关论文
共 39 条
  • [1] Noncontrast magnetic resonance for the diagnosis of cardiac amyloidosis, JACC Cardiovasc Imaging, 13, 1, (2020)
  • [2] Automated cardiovascular magnetic resonance image analysis with fully convolutional networks. J Cardiovasc Magn Reson 20(1):65. 10.1186/s12968-018-0471-x, (2018)
  • [3] Bhuva A., Bai W., Lau C., Davies R., Ye Y., Bulluck H., McAlindon E., Culotta V., Swoboda P., Captur G., Treibel T., Augusto J., Knott K., Seraphim A., Cole G., Petersen S., Edwards N., Greenwood J., Bucciarelli-Ducci C., Hughes A., Rueckert D., Moon J., Manisty C., A multicenter, scan-rescan, human and machine learning CMR study to test generalizability and precision in imaging biomarker analysis, Circ Cardiovasc Imaging, 12, 10, (2019)
  • [4] Carrick D., Haig C., Ahmed N., McEntegart M., Petrie M.C., Eteiba H., Hood S., Watkins S., Lindsay M.M., Davie A., Mahrous A., Mordi I., Rauhalammi S., Sattar N., Welsh P., Radjenovic A., Ford I., Oldroyd K.G., Berry C., Myocardial hemorrhage after acute reperfused ST-segment-elevation myocardial infarction: Relation to microvascular obstruction and prognostic significance, Circ Cardiovasc Imaging, 9, 1, (2016)
  • [5] Chaikriangkrai K., Abbasi M.A., Sarnari R., Dolan R., Lee D., Anderson A.S., Ghafourian K., Khan S.S., Vorovich E.E., Rich J.D., Wilcox J.E., Blaisdell J.A., Yancy C.W., Carr J., Markl M., Prognostic value of myocardial extracellular volume fraction and T2-mapping in heart transplant patients, JACC Cardiovasc Imaging, (2020)
  • [6] Chang S., Lee W.W., Chun E.J., (2019)
  • [7] Demirkiran A., Everaars H., Amier R.P., Beijnink C., Bom M.J., Gotte M.J.W., van Loon R.B., Selder J.L., van Rossum A.C., Nijveldt R., (2019)
  • [8] Ferreira V.M., Schulz-Menger J., Holmvang G., Kramer C.M., Carbone I., Sechtem U., Kindermann I., Gutberlet M., Cooper L.T., Liu P., Friedrich M.G., Cardiovascular magnetic resonance in nonischemic myocardial inflammation: Expert recommendations, J am Coll Cardiol, 72, 24, pp. 3158-3176, (2018)
  • [9] Friedrich M.G., Sechtem U., Schulz-Menger J., Holmvang G., Alakija P., Cooper L.T., White J.A., Abdel-Aty H., Gutberlet M., Prasad S., Aletras A., Laissy J.-P., Paterson I., Filipchuk N.G., Kumar A., Pauschinger M., Liu P., Cardiovascular magnetic resonance in myocarditis: A JACC white paper, J am Coll Cardiol, 53, 17, pp. 1475-1487, (2009)
  • [10] Greenwood J.P., Maredia N., Younger J.F., Brown J.M., Nixon J., Everett C.C., Bijsterveld P., Ridgway J.P., Radjenovic A., Dickinson C.J., Ball S.G., Plein S., Cardiovascular magnetic resonance and single-photon emission computed tomography for diagnosis of coronary heart disease (CE-MARC): A prospective trial, Lancet, 379, 9814, pp. 453-460, (2012)
1234